Immunoassay Interference Blocker Market
Immunoassay Interference Blocker market study with corona crisis impact assessment and outlook, regional analysis, market share, market size, and regulatory frame work analysis. Know how impact of COVID-19 outbreak will lead to change in company market share.
Global Market Study on Immunoassay Interference Blocker: ‘In Vitro’ Diagnostics Rapidly Advancing
- Report code : PMRREP24343 |
- Industry : Life Sciences & Transformational Health |
- Published On : Jul-2019 |
- Pages : 245 Pages |
- Format :
Continual developments in the healthcare sector remain a catalyzing factor for improved research capabilities. Rapid investments in research and development to gain advancements in clinical diagnosis and the improve results of biochemical analysis. Constant clinical efforts towards improving disease diagnosis in a bid to offer effective patient care to individuals remains pivotal for healthcare professionals. Laboratory test results, including immunoassay results, influence about 70 percent of healthcare decisions. When healthcare decisions are built on inaccurate results owing to biotin interference, there is a risk of inappropriate and sometimes irreversible treatment.
Persistence Market Research (PMR) has conducted a detailed assessment of the immunoassay interference blocker involving a global market perspective on the acceptance of immunoassay interference blockers owing to growing prevalence of chronic diseases that create the need for effective and accurate clinical results. Factors supporting the demand growth such as continual technological advancements and growing demand for better diagnosis, are also discussed in the report.
Growth Path of the Immunoassay Interference Blocker Market
The evolution of immunoassay has brought substantial benefits in terms of analytical, operational, and clinical outcomes. The major types of immunoassay interference blockers have evolved back in the 1990s, but they became significant over the past fifteen years. The market for immunoassay interference blocker reagents and kits derived from Human serum or animal serum boomed over this age. Effective sales of immunoassay interference blocker including antibody interference blockers and detection interference blockers began in early 2000.
Over the years, immunoassay techniques have been the major highlighted products both in the diagnostic testing and proteomic research. More usage of immunoassay techniques in oncology research and high demand for immunoassay based testing were observed. The immunoassay interference blocker market is expected to generate a revenue of ~210 US$ Mn in 2019, and is expected to grow at a CAGR of ~6.5% over the period of forecast. Increased demand for new expertise and advancements in vitro diagnostics techniques have led to the growth of immunoassay interference blocker market.
The Impact of Undercurrents
Technological Advancements Push R&D capabilities
Manufacturing companies in immunoassay interference blocker market are concentrating on bringing new technologies and kits that could aid in effective diagnosis. This is expected to throw light on aggressiveness of progress of cancer and other viral and infectious diseases and expected patient survival period. Technological advancements aid in pushing the capabilities of research and development to bolster developments in immunoassay interference blocker market.
Rising Prevalence of Chronic Diseases
The rising incidences of chronic diseases along with the global increase in geriatric population is expected to increase the demand for diagnostic kits and reagents for the detecting age-related and other chronic conditions, which is expected to boost the immunoassay interference blocker market. Effective immunoassay interference blockers aid in improved diagnostics, thereby driving the product demand.
The market growth is going to be restricted by the lack of product awareness and increasing cost of immunoassay procedures in low and middle income countries. Along with this, owing to the low or poor detection limit, it will be a restraining factor for the growth of immunoassay interference blocker market.
Competitors’ Winning Strategies
Enhance R&D Efforts for New Products
High throughput quality research & development, along with the advancements in immune blockers for ensuring steady and high-performance quality will aid market as one of the fastest growing market in IVD products category with a healthy CAGR over the forecast period. Companies are focusing on improving their research and development activities to make therapies easier and safer for the users of biochemical testing products. Furthermore, the immunoassay interference blocker market is expected to be propelled by the increasing investments in research and development of molecular detection reagents.
Expand Detection Interference Blocker Portfolio
Although antibody interference blockers are expected to remain the sought-after product type, immunoassay interference blocker market competitors are expected to gain growth opportunities with the detection interference blocker portfolio which is likely to emerge as a high-growth variant during the period of forecast. Companies are expanding the detection interference blocker portfolio to capture a sizable share in the global market.
Corporate Tie-ups to Boost Distribution
Companies operating in the immunoassay interference blocker market continue to make efforts towards expanding their geographical footprint. Corporate tie-ups with domestic distributors enable them to extend their business across the lucrative regions, for providing Immunoassay Interference Blocker reagents to a larger consumer base. Increasing strategic collaborations and agreements among leading companies for manufacturing dual chamber prefilled syringe is expected to boost the revenue growth of the immunoassay interference blocker market.
Competitive Landscape Analysis
In May 2019, Roche Ltd. announced the worldwide launch of what the company claims to be the first and only in vitro diagnostic assay for ROS1 immunohistochemistry. The test identifies the ROS1 protein present in the tissue, and could be beneficial in recognizing ROS1-positive incidences of cancer.
In April 2019, Bio-Rad Laboratories, Inc., a leader of life science research and clinical diagnostic offerings, announced the grant of FDA clearance for its BioPlex 2200 Lyme Total Assay, which is an innovative multiplex test method to aid in the diagnosis of Lyme disease.
The immunoassay interference blocker market remains consolidated with leading players comprising of 65 to 70% share in the global market. Leading companies are emphasizing on expanding their position in the global market by means of new product development. Another vital strategy catalyzing growth of the immunoassay interference blocker market is the product diversification strategy. Primarily other players are focused on manufacturing Antibody Interference Blocker kits and reagents simultaneously, diversifying into other products. Manufacturers are focused on developing novel products with competitive pricing, thus expecting to increase their respective market shares.
Analysts’ Perspective of the Market
The PMR analysts’ have a positive perspective of the immunoassay interference blocker market. The market has grown rapidly and has a major share in global diagnostics market. The growth of market is anticipated to increase significantly in the forecast period owing to increasing prevalence of chronic and other infectious disease. The increasing preference for low cost products are garnering competitors’ attention, wherein they aim to cater market demand. This is made possible with the help of technological advancements in production of interference blockers. New market entrants can imbibe similar strategies to gain market profitability. North America continues to remain the leading immunoassay interference blocker market owing to increasing demand of immunoassay interference blocker reagents and kits from biotechnology industry as well as academic and research institutes. Increasing molecular diagnosis, particularly in North American countries is likely to shape the future of the immunoassay interference blocker market in this region. Apart from this, East Asia is also expected to offer growth prospects to the immunoassay interference blocker market players, where major demand is created by academic and research institutes. Companies seeking opportunities in the immunoassay interference blocker market could consider East Asia for investments in the immunoassay interference blocker business.
Read More
High Demand for Rapid Immunoassay Testing Driving the Demand for Immunoassay Interference Blocker Kits and Reagents
Growing prevalence of infectious and chronic diseases, high penetration of immunoassays in oncology, coupled with the high demand for rapid immunoassay testing leads are among the key factors that are expected to increase the demand for immunoassay interference blocker kits and reagents. This is estimated to boost the immunoassay interference blocker kits and reagents market.
During the manufacturing of diagnostic immunoassay reagent development kits, it is necessary to ensure consistent quality as well as high performance, which are among the key factors to ensure success. Immunoassay interference poses a significant threat to the assay quality, as well as has a far-reaching impact on the quality of the result. The introduction of optimal interference blocking kits and solutions that can be easily incorporated into diagnostic immunoassays and deliver efficiency to molecular operations has emerged as a potential factor driving revenue generation in the global immunoassay interference blocker market.
Increasing Requirement of Immunoassay Interference Blockers with High Proven Blocking Efficiency to offer Growth Opportunities in the Immunoassay Interference Blocker Market
Factors such as proven blocking efficiency, secured global supply of immunoassay blocking solutions at any scale, the cost-effectiveness of these solutions, consistent quality, and transparent formulation & customization have substantially boosted the growth of the immunoassay interference blocker market. Key players in the immunoassay interference blocker market are focused on creating and delivering high-performance immunoassay components that can be effortlessly implemented with minimal product cost and effort. Moreover, immunoassay interference blockers have a long shelf life, along with consistent test quality and high purity. This is anticipated to drive revenue generation in the immunoassay interference blocker market in countries in Asia and Europe. However, FDA approvals for immunoassay interference blocker kits and reagents are severely deterring the expansion of the global market of immunoassay interference blockers.
Immunoassay Considered to be among the Most Sensitive Biochemical Testing, Thus Offering Revenue Generation Opportunities to Key Manufacturers
Immunoassays are considered to be a highly sensitive biochemical testing methods that are used for determining the macromolecule concentration in any target solution via an antibody or antigen for improved and efficient results. Over the recent years, immunoassays have created a major impact on diagnostic testing as well as scientific research, which has grown rapidly, thus boosting the revenue share of immunoassay interference blockers in the global In Vitro Diagnostics (IVD) market.
However, false and unreliable immunoassay outcomes as a result of interference are likely to lead to misinterpretation, which is likely to result in inappropriate treatment. This factor is creating the need for highly efficient diagnostics, thereby boosting the global demand for immunoassay interference blocker reagents and kits. Optimal blocking solutions for reliable immunoassays play an important role in carrying out effective immunoassays.
Competitive Landscape
The competition section of the immunoassay interference blocker market features the profiles of the key players operating in the market based on their shares, differential strategies, product offerings, marketing approach, and company dashboard. Some of the key players operating in the immunoassay interference blocker market include
- Abcam plc
- AMS Biotechnology (Europe) Limited
- Aviva Systems Biology Corporation
- Bio-Rad Laboratories, Inc.
- Meridian Bioscience, Inc.
- Roche Diagnostics GmbH
- Rockland Immunochemicals, Inc.
- Scantibodies Laboratory, Inc.
- Thermo Fisher Scientific, and others.
Definition
In the diagnostic immunoassay development and reagent kits manufacturing, the key to market success along with a good reputation for the manufacturer is to consistently ensure high performance quality. A significant threat to immunoassay quality has been posed by Immunoassay interferences and its impact is comprehensive. Thus, optimal blocking technology could be the critical element that assists the elimination of potential interferences and positions the product above the competition. There are various powerful blockers that have been designed to eliminate the most common types of immunoassay interferences. These include antibody interference blockers, detection interference blockers, and surface interference blockers.
About the Report
PMR has conducted a research study on the immunoassay interference blocker market for the forecast period 2019 to 2029. The immunoassay interference blocker market report offers a comprehensive evaluation of the business opportunities available in the immunoassay interference blocker market, along with insights on the consumption of immunoassay interference blocker reagents, incidence of diseases such as diabetes, the reimbursement scenario for molecular diagnostic reagents, and the competitive landscape of the immunoassay interference blocker market. The report elaborates on the macroeconomic factors that are influencing the dynamics of the immunoassay interference blocker market, along with its futuristic potential.
Segmentation
The report offers a comprehensive taxonomy of the immunoassay interference blocker market based on the product type, application, end user, and region. Distinct immunoassay interference blockers in the market include antibody interference blockers, detection interference blockers, and surface interference blockers. Antibody immunoassay interference blocker registered a substantial revenue in the product segment. The immunoassay interference blocker market has been thoroughly analyzed across the regions of North America, Latin America, Europe, South Asia, East Asia, Oceania, and MEA.
Additional Questions Answered
Some of the additional questions addressed in the immunoassay interference blocker market report are:
- What is the revenue potential of the immunoassay interference blocker market across the regions of North America and Europe?
- Who are the key competitors in the immunoassay interference blocker market and what are their portfolios?
- What are the major challenges affecting the growth of the immunoassay interference blocker market?
- How is the reimbursement landscape in the immunoassay interference blocker market impacting the growth of the market?
Research Methodology
The immunoassay interference blocker market has been estimated based on the consumption and supply-demand approach. The market was first calculated based on the consumption of immunoassay interference blockers and the sales of these reagents and kits in different regions/countries, especially in the top 20 countries globally, for chronic disease indications. Other qualitative factors analyzed during the value estimation of immunoassay interference blockers include the level of awareness regarding the availability of products.
This information is further validated with thorough primary research, which includes surveys, interviews, and in-person interactions, along with the viewpoints of seasoned analysts, and secondary research, which comprises authentic trade journals, resourceful databases, and verified paid sources. The research study on the immunoassay interference blocker market also includes the top trends and macro as well as microeconomic factors shaping the immunoassay interference blocker market. With this approach, the report on the immunoassay interference blocker market estimates the industry attractiveness of every major segment of the immunoassay interference blocker market over the forecast period.
Persistence Market Research (PMR) recently published a report on the immunoassay interference blocker market that provides readers with an overall market outlook with the help of an extensive market analysis. The PMR report on immunoassay interference blocker market examines the historical and current market scenario and offers a forecast for the period, 2019-2029.
The PMR study helps companies in this landscape gain a complete idea of the market and aid in taking key business decisions with the help of vital findings and exclusive insights into the immunoassay interference blocker market. The PMR report offers an assessment of the key dynamics of the immunoassay interference blocker market which includes market drivers, industry trends, and opportunities held by the market. The PMR report is divided in key sections that allows the report audience to gain a detailed understanding of individual aspects of the report on the immunoassay interference blocker market.
Global Immunoassay Interference Blocker Market Taxonomy
|
Product Type |
Application |
End User |
Region |
|
Antibody Interference Blockers |
Sandwich Immunoassay |
Academic & Research Institutes |
North America |
|
Antibody Capture Assays |
Biotechnology Companies |
Latin America |
|
Competitive ELISA |
Contract Research Organizations |
Europe |
|
Others |
Molecular Diagnostics Companies |
East Asia |
|
South Asia |
||
|
Oceania |
||
|
Middle East & Africa |
||
|
|||
|
Detection Interference Blockers |
|||
|
|||
|
|||
|
|||
|
|||
|
Surface Interference Blockers |
|||
|
|||
|
|||
|
|||
|
|||
|
Key Questions Answered in the Report
- How much will the immunoassay interference blocker market value in the 2029?
- What are key trends that are likely to shape the immunoassay interference blocker market in the coming years?
- Which type is likely to remain the sought-after immunoassay interference blocker type over the next ten years?
- What are the key challenges that are likely to impact the immunoassay interference blocker market competitors over the years?
- Which countries are expected to remain profitable avenues for the immunoassay interference blocker business?
PMR’s study on immunoassay interference blocker market begins with an executive summary that sheds light on the various immunoassay interference blocker market aspects covered in the report. The section offers an immunoassay interference blocker market outlook, market trends, and showcases the significance of taking up the study. This chapter includes the recommendations and analysis of the expert analysts at PMR who have formulated the report.
The next chapter in the immunoassay interference blocker market is the market overview that offers an outlook into the immunoassay interference blocker market in terms of the market scope, definition, and limitations. The study includes analysis of reimbursement scenario and supply chain analysis. Following this is the market background which includes a detailed understanding of the macro-economic factors impacting the immunoassay interference blocker market. The immunoassay interference blocker market report also studies the significant market dynamics including market drivers, trends, and restraints.
The next chapter offers an outlook of the global immunoassay interference blocker market analysis and forecast in terms of both volume and value. The section provides an assessment of key segments in the immunoassay interference blocker market on the basis of product type, application, end user, and region. The analysis includes the bifurcation on the basis of these segments. Clients are able to identify promising avenues with the help of this evaluation of the immunoassay interference blocker market segments. The inclusion of year-on-year growth projection and basis point share analysis further aids in decision-making.
The next chapter in the PMR study on the immunoassay interference blocker market offers an evaluation of the regional landscape. The regional assessment allows industry players to make key strategic decisions in terms of geographical expansion and investments. The segment-wise and country-level evaluation of individual regions helps the audience of the immunoassay interference blocker market study to identify potential opportunities in key regions. Backed with year-on-year growth projections, global value and volume share, this section is a vital section in the report on immunoassay interference blocker market.
The report on immunoassay interference blocker market by PMR offers a unique competitive assessment of the key market players. This sections offers an overview of the nature of the immunoassay interference blocker market with the help of the market share held by leading and emerging players. The unique dashboard view of the players in the immunoassay interference blocker market allows readers to understand the key strategies implemented by individual players and their performance in the immunoassay interference blocker market featuring the focus areas of the immunoassay interference blocker market players. Additionally, the competitive structure of prominent players in the immunoassay interference blocker market is also discussed in the study.
Research Methodology
The PMR analysis on the immunoassay interference blocker market is based on a detailed assessment of the market including both primary and secondary research. The in-depth assessment of the immunoassay interference blocker market in terms of the competitive landscape is backed with evaluation of various aspects on an individual level pertaining to the market. An analysis of the historical and current market for immunoassay interference blocker with a focus on key market segments and major regions, along with other qualitative inputs help the PMR analysts derive at a crucial predictions along with a forecast analysis for the immunoassay interference blocker market. Readers can access the immunoassay interference blocker market report to gain a forecasted market assessment for the period, 2019 – 2029.
Companies covered in Immunoassay Interference Blocker Market Report
Company Profiles:
- Abcam plc
- AMS Biotechnology (Europe) Limited
- Aviva Systems Biology Corporation
- Bio-Rad Laboratories, Inc.
- Meridian Bioscience, Inc.
- Roche Diagnostics GmbH
- Rockland Immunochemicals, Inc.
- Scantibodies Laboratory, Inc.
- Thermo Fisher Scientific
